𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mortality from Parkinson's disease: A population-based prospective study (NEDICES)

✍ Scribed by Ignacio J. Posada; Julián Benito-León; Elan D. Louis; Rocío Trincado; Alberto Villarejo; María José Medrano; Félix Bermejo-Pareja


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
199 KB
Volume
26
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Most studies of mortality in Parkinson's disease have been clinical studies, yielding results that are not representative of the general population. We assessed the risk of mortality from Parkinson's disease in the Neurological Disorders in Central Spain (NEDICES) study, a prospective population‐based study in which Parkinson's disease patients who were not ascertained through medical practitioners were also included. The cohort consisted of 5262 elderly subjects (mean baseline age, 73.0 years), including 81 with Parkinson's disease at baseline (1994–1995). Thirteen‐year mortality was assessed. Two thousand seven hundred and one of 5262 subjects (51.3%) died over a median follow‐up of 12.0 years (range, 0.04–14.8 years), including 66 of 81 subjects (81.5%) with Parkinson's disease at baseline and 2635 of 5181 subjects (50.8%) without Parkinson's disease at baseline. In an unadjusted Cox model, the hazard ratio of mortality was increased in subjects with Parkinson's disease (hazard ratio, 2.29; 95% confidence interval, 1.80–2.93; P < .001) versus subjects without Parkinson's disease (reference group). In a Cox model that adjusted for a variety of demographic factors and comorbidities, the risk of mortality remained elevated in subjects with Parkinson's disease (hazard ratio, 1.75; 95% CI, 1.32–2.31, P < .001). In additional Cox models, Parkinson's disease patients with dementia had particularly high risks of mortality (adjusted hazard ratio, 2.62; 95% CI, 1.40–4.90; P < .001). In this prospective population‐based study, Parkinson's disease was an independent predictor of mortality in the elderly. Parkinson's disease patients with dementia had particularly high risks of mortality. © 2011 Movement Disorder Society


📜 SIMILAR VOLUMES


Comorbid conditions associated with Park
✍ Cynthia L. Leibson; Demetrius M. Maraganore; James H. Bower; Jeanine E. Ransom; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

## Abstract The burden of comorbidity in Parkinson's disease (PD) remains unclear. All Olmsted County, Minnesota, residents with incident PD in 1976–1995 (n = 197) plus one age‐ and sex‐matched non‐PD referent subject per case were followed for all clinical diagnoses from 5 years before through 15

Neuropathology of dementia in Parkinson'
✍ Dag Aarsland; Robert Perry; Andrew Brown; Jan P. Larsen; Clive Ballard 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 3 views

## Abstract Twenty‐two patients with Parkinson's disease drawn from a community‐based study were followed prospectively until their deaths. Even though 18 patients had dementia, none fulfilled Braak and Braak or The National Institute on Aging and Ronald and Nancy Reagan Institute of the Alzheimer'

Incidence of Parkinson's disease and aty
✍ Yaroslav Winter; Yury Bezdolnyy; Elena Katunina; Gagik Avakjan; Jens P. Reese; J 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

## Abstract Data on the incidence of Parkinson's disease (PD) and atypical parkinsonian syndromes (APS) in East European countries and Asia are limited. The objective of this prospective population‐based study was to determine the incidence of PD and APS in the Russian population. The study area wa

Chemical exposures and Parkinson's disea
✍ Roberta Frigerio; Kevin R. Sanft; Brandon R. Grossardt; Brett J. Peterson; Alexi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 2 views

## Abstract The putative association between pesticide exposures and Parkinson's disease (PD) remains controversial. We identified all subjects who developed PD in Olmsted County, Minnesota, from 1976 through 1995, and matched them by age (± 1 year) and sex to general population controls. We assess

Direct medical costs associated with Par
✍ Cynthia L. Leibson; Kirsten Hall Long; Demetrius M. Maraganore; James H. Bower; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

## Abstract The objective was to provide population‐based estimates of incremental medical costs associated with Parkinson's disease (PD) from onset forward. All Olmsted County, Minnesota, residents with confirmed PD onset from 1987 through 1995 (n = 92) and one age‐ and sex‐matched non‐PD referent

Incidence of Parkinson's disease and par
✍ Jan Linder; Hans Stenlund; Lars Forsgren 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

## Abstract The differential diagnosis of parkinsonian disorders is difficult, especially early in the course of the diseases. The clinical subtypes of Parkinson's disease (PD) have not so far been described in newly diagnosed patients. We present a prospective incidence cohort study of patients wi